Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Jul 2, 2024, 4:00 PM
1.270
+0.060 (4.96%)
After-hours: Jul 2, 2024, 4:44 PM EDT
Cyclo Therapeutics Revenue
Cyclo Therapeutics had revenue of $1.13M in the twelve months ending March 31, 2024, down -15.51% year-over-year. Revenue in the quarter ending March 31, 2024 was $202.45K with 32.83% year-over-year growth. In the year 2023, Cyclo Therapeutics had annual revenue of $1.08M, a decrease of -21.76%.
Revenue (ttm)
$1.13M
Revenue Growth
-15.51%
P/S Ratio
30.74
Revenue / Employee
$140,806
Employees
8
Market Cap
34.62M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.08M | -299.36K | -21.76% |
Dec 31, 2022 | 1.38M | -210.00K | -13.24% |
Dec 31, 2021 | 1.59M | 682.38K | 75.54% |
Dec 31, 2020 | 903.38K | -103.82K | -10.31% |
Dec 31, 2019 | 1.01M | -4.28K | -0.42% |
Dec 31, 2018 | 1.01M | -226.28K | -18.28% |
Dec 31, 2017 | 1.24M | -265.15K | -17.64% |
Dec 31, 2016 | 1.50M | 552.45K | 58.13% |
Dec 31, 2015 | 950.46K | -616.98K | -39.36% |
Dec 31, 2014 | 1.57M | -125.90K | -7.43% |
Dec 31, 2013 | 1.69M | 648.39K | 62.05% |
Dec 31, 2012 | 1.04M | 13.09K | 1.27% |
Dec 31, 2011 | 1.03M | 229.48K | 28.60% |
Dec 31, 2010 | 802.37K | 178.50K | 28.61% |
Dec 31, 2009 | 623.87K | 128.94K | 26.05% |
Dec 31, 2008 | 494.94K | -256.24K | -34.11% |
Dec 31, 2007 | 751.18K | 208.86K | 38.51% |
Dec 31, 2006 | 542.31K | 87.95K | 19.36% |
Dec 31, 2005 | 454.36K | -10.33K | -2.22% |
Dec 31, 2004 | 464.69K | 70.16K | 17.78% |
Dec 31, 2003 | 394.53K | -127.84K | -24.47% |
Dec 31, 2002 | 522.37K | 232.95K | 80.49% |
Dec 31, 2001 | 289.43K | 30.47K | 11.77% |
Dec 31, 2000 | 258.96K | -233.17K | -47.38% |
Dec 31, 1999 | 492.13K | 271.31K | 122.87% |
Dec 31, 1998 | 220.82K | -78.30K | -26.18% |
Dec 31, 1997 | 299.12K | -44.95K | -13.06% |
Dec 31, 1996 | 344.07K | - | - |
Dec 31, 1995 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nortech Systems | 138.66M |
Concord Medical Services Holdings | 75.80M |
Owlet | 58.02M |
Aadi Bioscience | 23.84M |
ImmuCell | 21.28M |
Precision Optics Corporation | 19.41M |
DarioHealth | 19.04M |
CYTH News
- 7 days ago - Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024 - Business Wire
- 4 weeks ago - Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1 - Business Wire
- 6 weeks ago - Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer's Disease - Business Wire
- 5 months ago - Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office - Business Wire
- 6 months ago - Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. - Business Wire
- 7 months ago - Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1 - Business Wire